Busy times for Telix

Telix has had a big month, and the last couple of weeks has added to it. It has formed a new company, had a co-founder step down, and the FDA has accepted its New Drug Application in an area of unmet medical need.

To see the whole article please log in.

Our old access system is being retired.

Please create a password and click 'Log in' for ongoing access.

Please choose a password to secure your access to Pharma in Focus (minimum 8 characters).

You're here because you requested to reset your password.

Please choose a new password (minimum 8 characters).

To search the News Archive you need to be logged in.

Retype password

Not a member? Sign up here